Opt-In HCP + Patient Data Access: How to Build a Target List That Converts
Learn how US pharma teams build opt-in HCP and patient target lists that convert using NPI matching, permissions, enrichment, suppression, and measurement.
Recent posts
Opt-In HCP + Patient Data Access: How to Build a Target List That Converts
HIPAA & Data Privacy Update 2026: What Pharma Marketers Need to Know
2026 HIPAA & privacy update for pharma marketers: authorization, de-identification, FTC/state laws, trackers, BAAs, and a practical checklist.
Personalizing Patient Journeys with AI‑Driven Healthcare CRM
Explore New Options in 2026 Pharmaceutical marketers face a changing landscape. The traditional one‑size‑fits‑all campaign model no longer meets expectations. Patients and health‑care professionals (HCPs) are accustomed to personalized digital…
Case Study: From Data Silos to Prescriber Growth
How an osteoporosis brand unified HCP engagement — and drove a 15% lift in prescribers In the competitive world of osteoporosis treatment, where the aging population continues to swell and…
Cookieless Measurement for HCP Targeting: Identity Options Beyond Third-Party Cookies
Third-party cookies were never a perfect way to measure and optimize healthcare professional (HCP) campaigns. Even when they “worked,” they were fragile (browser limits, ITP/ETP, cross-device gaps), difficult to govern,…
Pulse Health x Sermo Integration Guide: Getting the Most out of Both Platforms
Sermo’s Role in Pharma Marketing The health‑care marketing landscape has shifted dramatically in recent years. Physicians now expect personalized, data‑driven interactions that respect their time and professional independence. Social media…
ODAIA and Pulse Health Partner to Help Pharma Convert More HCPs and Increase Patient Prescription Volume
ODAIA marketing intelligence combined with Pulse Health’s platform deliver AI-powered marketing orchestration for personalized HCP engagement. SAN FRANCISCO – JP Morgan Healthcare Conference – Jan. 14, 2026 ODAIA and Pulse…
Designing a Preference Center That HCPs Actually Use (and Compliance Teams Approve)
HCPs don’t ignore digital — they ignore irrelevant, over-frequent, hard-to-control outreach. A preference center is your chance to fix that while proving to compliance that consent and communication controls are…
Top Pharmaceutical Industry Marketing Strategies for 2026
Pharmaceutical industry marketing is crucial for promoting new drugs and healthcare solutions. Drug companies are key players in pharmaceutical industry marketing and must adapt their strategies to effectively connect with…
Compliance‑First Email & SMS in Pharma: A Practical Playbook
Pharma marketers don’t just compete for attention — they compete for trust. In regulated industries, a clever subject line or snappy text is never worth a compliance misstep. This playbook…
Personalizing Radiology Engagement: How Pulse Health Can Maximize Your RSNA 2025 Impact — Even Without Attending
Turning RSNA 2025 momentum into year-round HCP engagement with Pulse Health. Each year, RSNA brings together thousands of radiologists, imaging professionals, and industry leaders under the banner of “Imaging the…
Pulse × Doximity: Verified HCP identity and unified media performance — together in one engagement cloud
With the Pulse–Doximity integration, life‑sciences teams can (1) verify HCP identity with low friction, (2) unify Doximity campaign performance alongside the rest of their media, CRM, and web analytics, and…
How Pharma Teams Use Email + SMS to Drive Real HCP Engagement
In today’s noisy digital landscape, getting the attention of healthcare professionals (HCPs) is harder than ever. Physicians and pharmacists are bombarded daily with information — from journal updates and sales…
Unlocking Maximum Value at #AHA25 — And How Pulse Health Can Help
As the cardiovascular and brain-health community prepares for AHA Scientific Sessions 2025 (Nov 7-10 in New Orleans) — four full days of practice-changing science and innovation. (professional.heart.org) For life-sciences companies,…
Maximizing Pharma Marketing ROI with Better Data
Stop Wasting Budget: How Data Quality Drives ROI in Pharma Budgets are tight and evidence demands are higher. If your data layer is messy — IDs don’t match, consent is…